Researchers at OSU are bringing science fiction style nanomedicine into the real world. The research will give manufacturers the information they need to make an anti-lung cancer inhaler.
The work, submitted for publication this month, detailed the use Nanostructured(meaning particles only a few billionths of an inch across) Lipid Carriers (NLC) and their efficacy as a means for delivering cancer drugs via inhalation versus traditional intravenous(IV) delivery.